Central serous chorioretinopathy: Treatment

Area of Science:

• Ophthalmology
• Retinal Diseases
• Choroidal Disorders

Background:

• Central serous chorioretinopathy (CSC) is a pachychoroid disease characterized by neurosensory retinal detachment and subretinal fluid.
• Its exact pathogenesis remains unclear but involves multifactorial causes, including choroidal dysfunction and vascular engorgement.

Purpose of the Study:

• To provide a comprehensive and updated understanding of Central Serous Chorioretinopathy (CSC).
• To focus on the various treatment modalities available for CSC management.

Main Methods:

• Review of existing literature on Central Serous Chorioretinopathy (CSC) treatments.
• Analysis of multimodal imaging techniques, particularly Optical Coherence Tomography Angiography (OCTA), for diagnosis and prognosis.
• Evaluation of therapeutic options including photodynamic therapy, laser treatments, and oral medications.

Main Results:

• Photodynamic therapy is effective for managing serous retinal detachment (SRD) in CSC.
• Micropulse diode laser photocoagulation and focal laser treatment are also utilized.
• Emerging treatments include oral mineralocorticoid receptor antagonists.
• Optical Coherence Tomography Angiography (OCTA) aids in understanding pathology, severity, prognosis, and detecting complications like choroidal neovascularization.

Conclusions:

• Multimodal imaging, especially OCTA, is crucial for diagnosing and managing CSC.
• While treatment consensus is lacking, various therapeutic options exist, with ongoing research into novel approaches like oral medications.